

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 5.96405836 |
| 2 | embryonic process involved in female pregnancy (GO:0060136) | 5.62174316 |
| 3 | establishment of apical/basal cell polarity (GO:0035089) | 4.64857033 |
| 4 | transcription from mitochondrial promoter (GO:0006390) | 4.63622490 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.56092013 |
| 6 | regulation of gene silencing by RNA (GO:0060966) | 4.40059427 |
| 7 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.40059427 |
| 8 | regulation of gene silencing by miRNA (GO:0060964) | 4.40059427 |
| 9 | regulation of translational fidelity (GO:0006450) | 4.31165912 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 4.29726046 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 4.29726046 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.29726046 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.29726046 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.29726046 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.29726046 |
| 16 | regulation of integrin activation (GO:0033623) | 4.10225231 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 4.07465862 |
| 18 | proline metabolic process (GO:0006560) | 4.06127895 |
| 19 | modulation by virus of host process (GO:0019054) | 4.03166022 |
| 20 | replication fork processing (GO:0031297) | 4.00835215 |
| 21 | establishment of monopolar cell polarity (GO:0061162) | 4.00429569 |
| 22 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 4.00429569 |
| 23 | modulation by symbiont of host cellular process (GO:0044068) | 3.95616401 |
| 24 | DNA deamination (GO:0045006) | 3.94017165 |
| 25 | histone H4-K12 acetylation (GO:0043983) | 3.88416260 |
| 26 | mitochondrial DNA metabolic process (GO:0032042) | 3.84203325 |
| 27 | dosage compensation (GO:0007549) | 3.82759513 |
| 28 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.80356528 |
| 29 | regulation of chromatin binding (GO:0035561) | 3.68248128 |
| 30 | trophectodermal cell differentiation (GO:0001829) | 3.68021868 |
| 31 | pre-miRNA processing (GO:0031054) | 3.66820031 |
| 32 | cellular response to virus (GO:0098586) | 3.66190475 |
| 33 | embryonic placenta development (GO:0001892) | 3.64608884 |
| 34 | heterochromatin organization (GO:0070828) | 3.62445951 |
| 35 | apoptotic process involved in morphogenesis (GO:0060561) | 3.60512805 |
| 36 | protein localization to kinetochore (GO:0034501) | 3.57249074 |
| 37 | protein localization to endosome (GO:0036010) | 3.55862521 |
| 38 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.54031852 |
| 39 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.51675433 |
| 40 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.51675433 |
| 41 | activation of MAPKKK activity (GO:0000185) | 3.51319816 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.51224113 |
| 43 | nodal signaling pathway (GO:0038092) | 3.50190153 |
| 44 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.44550036 |
| 45 | response to peptidoglycan (GO:0032494) | 3.44496173 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.44392640 |
| 47 | mitotic G1/S transition checkpoint (GO:0044819) | 3.42332855 |
| 48 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.36674808 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.36303195 |
| 50 | maternal placenta development (GO:0001893) | 3.34820542 |
| 51 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33220813 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.31774078 |
| 53 | regulation of early endosome to late endosome transport (GO:2000641) | 3.31093699 |
| 54 | mannose metabolic process (GO:0006013) | 3.28441083 |
| 55 | mitotic sister chromatid segregation (GO:0000070) | 3.26975298 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.26388193 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.26388193 |
| 58 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.25339360 |
| 59 | oxygen transport (GO:0015671) | 3.24942487 |
| 60 | erythrocyte maturation (GO:0043249) | 3.22080435 |
| 61 | regulation of hippo signaling (GO:0035330) | 3.16716449 |
| 62 | mRNA cleavage (GO:0006379) | 3.15205849 |
| 63 | G1 DNA damage checkpoint (GO:0044783) | 3.11399919 |
| 64 | negative regulation of cell cycle arrest (GO:0071157) | 3.09784207 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.08873439 |
| 66 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.07082271 |
| 67 | erythrocyte development (GO:0048821) | 3.06343296 |
| 68 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.03564733 |
| 69 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.99949008 |
| 70 | positive regulation of histone deacetylation (GO:0031065) | 2.96413650 |
| 71 | granulocyte differentiation (GO:0030851) | 2.92315230 |
| 72 | oxidative demethylation (GO:0070989) | 2.91141301 |
| 73 | negative regulation of mRNA processing (GO:0050686) | 2.91037028 |
| 74 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.90791132 |
| 75 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.90105494 |
| 76 | protein localization to chromosome, centromeric region (GO:0071459) | 2.90062218 |
| 77 | DNA unwinding involved in DNA replication (GO:0006268) | 2.89450022 |
| 78 | chromatin assembly (GO:0031497) | 2.89221635 |
| 79 | positive regulation by host of viral transcription (GO:0043923) | 2.89006409 |
| 80 | viral transcription (GO:0019083) | 2.86610440 |
| 81 | mitotic nuclear envelope disassembly (GO:0007077) | 2.84613157 |
| 82 | sister chromatid segregation (GO:0000819) | 2.84186506 |
| 83 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.82399260 |
| 84 | negative regulation of RNA splicing (GO:0033119) | 2.82398487 |
| 85 | polarized epithelial cell differentiation (GO:0030859) | 2.82323782 |
| 86 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 2.79606107 |
| 87 | * regulation of protein homooligomerization (GO:0032462) | 2.78449824 |
| 88 | base-excision repair (GO:0006284) | 2.77119081 |
| 89 | positive regulation of protein deacetylation (GO:0090312) | 2.76727542 |
| 90 | * intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.74590938 |
| 91 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72290864 |
| 92 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.72109697 |
| 93 | regulation of RNA export from nucleus (GO:0046831) | 2.72031365 |
| 94 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.72021338 |
| 95 | negative regulation of viral release from host cell (GO:1902187) | 2.71250730 |
| 96 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.71239750 |
| 97 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.70180665 |
| 98 | histone H4 deacetylation (GO:0070933) | 2.70059782 |
| 99 | membrane disassembly (GO:0030397) | 2.69318759 |
| 100 | nuclear envelope disassembly (GO:0051081) | 2.69318759 |
| 101 | viral protein processing (GO:0019082) | 2.68609517 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.68124670 |
| 103 | negative regulation of interleukin-12 production (GO:0032695) | 2.68010488 |
| 104 | DNA duplex unwinding (GO:0032508) | 2.67717358 |
| 105 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.66755213 |
| 106 | positive regulation of developmental pigmentation (GO:0048087) | 2.65561268 |
| 107 | histone H4-K5 acetylation (GO:0043981) | 2.65471202 |
| 108 | histone H4-K8 acetylation (GO:0043982) | 2.65471202 |
| 109 | * positive regulation of protein homooligomerization (GO:0032464) | 2.64813633 |
| 110 | detection of other organism (GO:0098543) | 2.64720240 |
| 111 | ribosome biogenesis (GO:0042254) | 2.64433976 |
| 112 | DNA geometric change (GO:0032392) | 2.64320582 |
| 113 | regulation of sister chromatid cohesion (GO:0007063) | 2.64011914 |
| 114 | germinal center formation (GO:0002467) | 2.63819693 |
| 115 | developmental programmed cell death (GO:0010623) | 2.63262057 |
| 116 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.62175563 |
| 117 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.62175563 |
| 118 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.62175563 |
| 119 | termination of RNA polymerase II transcription (GO:0006369) | 2.61295211 |
| 120 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.61076888 |
| 121 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60200198 |
| 122 | * positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.59241605 |
| 123 | neutrophil activation involved in immune response (GO:0002283) | 2.58947889 |
| 124 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.58715529 |
| 125 | protein insertion into membrane (GO:0051205) | 2.58285479 |
| 126 | detection of bacterium (GO:0016045) | 2.57708956 |
| 127 | regulation of gene silencing (GO:0060968) | 2.56902291 |
| 128 | virion assembly (GO:0019068) | 2.56794475 |
| 129 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.55160615 |
| 130 | stress fiber assembly (GO:0043149) | 2.54828186 |
| 131 | negative regulation of mRNA metabolic process (GO:1903312) | 2.54779326 |
| 132 | apoptotic process involved in development (GO:1902742) | 2.54711166 |
| 133 | DNA strand elongation (GO:0022616) | 2.54221654 |
| 134 | histone arginine methylation (GO:0034969) | 2.53858052 |
| 135 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 2.53098293 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.52822612 |
| 137 | tooth mineralization (GO:0034505) | 2.52728233 |
| 138 | gas transport (GO:0015669) | 2.52518334 |
| 139 | DNA strand renaturation (GO:0000733) | 2.52452735 |
| 140 | negative regulation of protein oligomerization (GO:0032460) | 2.52424631 |
| 141 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.52257027 |
| 142 | response to laminar fluid shear stress (GO:0034616) | 2.51721856 |
| 143 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.51461285 |
| 144 | regulation of ARF GTPase activity (GO:0032312) | 2.51083731 |
| 145 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.48586183 |
| 146 | retinoic acid receptor signaling pathway (GO:0048384) | 2.48561240 |
| 147 | positive thymic T cell selection (GO:0045059) | 2.47740118 |
| 148 | regulation of mast cell degranulation (GO:0043304) | 2.47360841 |
| 149 | regulation of double-strand break repair (GO:2000779) | 2.47315057 |
| 150 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.47120144 |
| 151 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.47094220 |
| 152 | positive regulation of receptor recycling (GO:0001921) | 2.45066410 |
| 153 | positive regulation of chromosome segregation (GO:0051984) | 2.44954784 |
| 154 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.44423005 |
| 155 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43714789 |
| 156 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.43638719 |
| 157 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43402094 |
| 158 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.43156780 |
| 159 | translational termination (GO:0006415) | 2.42869354 |
| 160 | cell-cell junction maintenance (GO:0045217) | 2.42494414 |
| 161 | cell migration in hindbrain (GO:0021535) | 2.42307790 |
| 162 | thymic T cell selection (GO:0045061) | 2.42203714 |
| 163 | respiratory system process (GO:0003016) | 2.41573255 |
| 164 | mitochondrial RNA metabolic process (GO:0000959) | 2.41468649 |
| 165 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41455576 |
| 166 | mRNA stabilization (GO:0048255) | 2.40824049 |
| 167 | RNA stabilization (GO:0043489) | 2.40824049 |
| 168 | spindle assembly (GO:0051225) | 2.40723204 |
| 169 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.40717365 |
| 170 | regulation of response to osmotic stress (GO:0047484) | 2.40336374 |
| 171 | vagina development (GO:0060068) | 2.40114405 |
| 172 | viral mRNA export from host cell nucleus (GO:0046784) | 2.40005885 |
| 173 | intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332) | 2.39212326 |
| 174 | negative regulation of granulocyte differentiation (GO:0030853) | 2.38691000 |
| 175 | regulation of protein heterodimerization activity (GO:0043497) | 2.38308830 |
| 176 | myeloid dendritic cell differentiation (GO:0043011) | 2.38123882 |
| 177 | tolerance induction (GO:0002507) | 2.36964790 |
| 178 | response to host immune response (GO:0052572) | 2.36099387 |
| 179 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.36099387 |
| 180 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.35520924 |
| 181 | regulation of leukocyte degranulation (GO:0043300) | 2.35225323 |
| 182 | modulation by virus of host morphology or physiology (GO:0019048) | 2.34571910 |
| 183 | * negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.32420614 |
| 184 | activation of Rac GTPase activity (GO:0032863) | 2.32024776 |
| 185 | adherens junction assembly (GO:0034333) | 2.31870421 |
| 186 | negative regulation of glial cell proliferation (GO:0060253) | 2.31522596 |
| 187 | negative regulation of necroptotic process (GO:0060546) | 2.31448197 |
| 188 | regulation of defense response to virus by virus (GO:0050690) | 2.31257888 |
| 189 | response to host defenses (GO:0052200) | 2.30901375 |
| 190 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.30901375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.39185585 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.86982290 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 2.79040191 |
| 4 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.72636328 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.69056691 |
| 6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.58290416 |
| 7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.58290416 |
| 8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.58290416 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.55052488 |
| 10 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.40577814 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.37428886 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.33929146 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25339682 |
| 14 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.25120205 |
| 15 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.12006704 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.10112373 |
| 17 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04136211 |
| 18 | * KDM2B_26808549_Chip-Seq_K562_Human | 2.01708641 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.91274736 |
| 20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.89059761 |
| 21 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.86426183 |
| 22 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.82652960 |
| 23 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78316670 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.78196709 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77716584 |
| 26 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.73966140 |
| 27 | P68_20966046_ChIP-Seq_HELA_Human | 1.73809569 |
| 28 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.71833859 |
| 29 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.71763097 |
| 30 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70131705 |
| 31 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.69067989 |
| 32 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.68641438 |
| 33 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.66564139 |
| 34 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.65210025 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.65112829 |
| 36 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.63781744 |
| 37 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.59973830 |
| 38 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.58694891 |
| 39 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58613357 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.58537051 |
| 41 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.57027406 |
| 42 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54012906 |
| 43 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.54004447 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.52360664 |
| 45 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51747913 |
| 46 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.51403031 |
| 47 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48408013 |
| 48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.47071520 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46685885 |
| 50 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.45697229 |
| 51 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.45690175 |
| 52 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45219656 |
| 53 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.43531321 |
| 54 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.43245740 |
| 55 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41485496 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41414552 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.40996290 |
| 58 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.38731673 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.36033007 |
| 60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.35505216 |
| 61 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34718448 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33089283 |
| 63 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.31779162 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31663456 |
| 65 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.30750336 |
| 66 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.30734718 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.30204225 |
| 68 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.29626492 |
| 69 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29382299 |
| 70 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.28606085 |
| 71 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28001160 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26550869 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26457498 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24517222 |
| 75 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24174655 |
| 76 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23844406 |
| 77 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23614132 |
| 78 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23377007 |
| 79 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21927260 |
| 80 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.21411641 |
| 81 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.20261375 |
| 82 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19846537 |
| 83 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.19589838 |
| 84 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18220243 |
| 85 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.17615564 |
| 86 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.17603833 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17329869 |
| 88 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16609728 |
| 89 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.16515564 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.16260404 |
| 91 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14149878 |
| 92 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13836513 |
| 93 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.13695590 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.13553946 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13166417 |
| 96 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13111766 |
| 97 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13089402 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12913931 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12317342 |
| 100 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.12230007 |
| 101 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.11795460 |
| 102 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.11557365 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11422649 |
| 104 | MAF_26560356_Chip-Seq_TH2_Human | 1.10607584 |
| 105 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.10293059 |
| 106 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.10041497 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09873526 |
| 108 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09800995 |
| 109 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.09694531 |
| 110 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09461549 |
| 111 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09437411 |
| 112 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08977626 |
| 113 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08008659 |
| 114 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07938094 |
| 115 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07606822 |
| 116 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07553826 |
| 117 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06888160 |
| 118 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.06428259 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.05893224 |
| 120 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.05765462 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.05588610 |
| 122 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.05524960 |
| 123 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.05407567 |
| 124 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.05337591 |
| 125 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.04986193 |
| 126 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04661709 |
| 127 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04291218 |
| 128 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.03758608 |
| 129 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02716788 |
| 130 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.02415253 |
| 131 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02388266 |
| 132 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.02103259 |
| 133 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.02090021 |
| 134 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.01635998 |
| 135 | SA1_27219007_Chip-Seq_Bcells_Human | 1.01406360 |
| 136 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.01392070 |
| 137 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00640827 |
| 138 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99830924 |
| 139 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99806486 |
| 140 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99640303 |
| 141 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99281873 |
| 142 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.99038498 |
| 143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98922930 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98792608 |
| 145 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97625234 |
| 146 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96775932 |
| 147 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.96346749 |
| 148 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.95840539 |
| 149 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95829840 |
| 150 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.95825260 |
| 151 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95762086 |
| 152 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95691788 |
| 153 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94738683 |
| 154 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94729148 |
| 155 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93834807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 3.98022624 |
| 2 | MP0009278_abnormal_bone_marrow | 2.98864714 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 2.97914170 |
| 4 | MP0008260_abnormal_autophagy | 2.77056715 |
| 5 | MP0005451_abnormal_body_composition | 2.69220826 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 2.52612910 |
| 7 | MP0005397_hematopoietic_system_phenotyp | 2.46226858 |
| 8 | MP0001545_abnormal_hematopoietic_system | 2.46226858 |
| 9 | MP0005076_abnormal_cell_differentiation | 2.39132187 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.38215881 |
| 11 | MP0003111_abnormal_nucleus_morphology | 2.36876871 |
| 12 | MP0005083_abnormal_biliary_tract | 2.35868233 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.26854412 |
| 14 | MP0010094_abnormal_chromosome_stability | 2.26848347 |
| 15 | MP0003077_abnormal_cell_cycle | 2.18907157 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.14609737 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 2.14550882 |
| 18 | MP0005257_abnormal_intraocular_pressure | 2.12812670 |
| 19 | MP0000685_abnormal_immune_system | 2.06224576 |
| 20 | MP0000490_abnormal_crypts_of | 2.02427314 |
| 21 | MP0004858_abnormal_nervous_system | 2.01738713 |
| 22 | MP0003123_paternal_imprinting | 1.97883917 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.96937509 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.96837934 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.84008883 |
| 26 | MP0010307_abnormal_tumor_latency | 1.81325673 |
| 27 | MP0000350_abnormal_cell_proliferation | 1.81079689 |
| 28 | MP0000678_abnormal_parathyroid_gland | 1.72690858 |
| 29 | MP0001348_abnormal_lacrimal_gland | 1.71029904 |
| 30 | MP0002086_abnormal_extraembryonic_tissu | 1.70419232 |
| 31 | MP0002419_abnormal_innate_immunity | 1.69270174 |
| 32 | MP0004947_skin_inflammation | 1.68449986 |
| 33 | MP0003890_abnormal_embryonic-extraembry | 1.68347313 |
| 34 | MP0005025_abnormal_response_to | 1.63081874 |
| 35 | MP0004197_abnormal_fetal_growth/weight/ | 1.61634606 |
| 36 | MP0001672_abnormal_embryogenesis/_devel | 1.53412508 |
| 37 | MP0005380_embryogenesis_phenotype | 1.53412508 |
| 38 | MP0002084_abnormal_developmental_patter | 1.51937203 |
| 39 | MP0003453_abnormal_keratinocyte_physiol | 1.51724193 |
| 40 | MP0001697_abnormal_embryo_size | 1.51405017 |
| 41 | MP0005000_abnormal_immune_tolerance | 1.49809416 |
| 42 | MP0003119_abnormal_digestive_system | 1.49015244 |
| 43 | MP0002089_abnormal_postnatal_growth/wei | 1.48922860 |
| 44 | MP0004510_myositis | 1.47565467 |
| 45 | MP0001730_embryonic_growth_arrest | 1.46210108 |
| 46 | MP0004133_heterotaxia | 1.45582138 |
| 47 | MP0008058_abnormal_DNA_repair | 1.44995540 |
| 48 | MP0006082_CNS_inflammation | 1.44044397 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.43734068 |
| 50 | MP0002085_abnormal_embryonic_tissue | 1.42692654 |
| 51 | MP0008007_abnormal_cellular_replicative | 1.41867183 |
| 52 | MP0009333_abnormal_splenocyte_physiolog | 1.40105490 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.39723090 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.38357193 |
| 55 | MP0003724_increased_susceptibility_to | 1.37053441 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.36427390 |
| 57 | MP0003984_embryonic_growth_retardation | 1.35733528 |
| 58 | MP0002398_abnormal_bone_marrow | 1.34935442 |
| 59 | MP0002723_abnormal_immune_serum | 1.34899123 |
| 60 | * MP0001819_abnormal_immune_cell | 1.34548951 |
| 61 | MP0002088_abnormal_embryonic_growth/wei | 1.34013299 |
| 62 | * MP0002420_abnormal_adaptive_immunity | 1.33473688 |
| 63 | MP0001293_anophthalmia | 1.31943933 |
| 64 | MP0002405_respiratory_system_inflammati | 1.31676850 |
| 65 | MP0009840_abnormal_foam_cell | 1.31032403 |
| 66 | MP0002080_prenatal_lethality | 1.30430371 |
| 67 | MP0002009_preneoplasia | 1.29894519 |
| 68 | MP0004264_abnormal_extraembryonic_tissu | 1.28701529 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.26115222 |
| 70 | MP0001533_abnormal_skeleton_physiology | 1.25897985 |
| 71 | * MP0000689_abnormal_spleen_morphology | 1.24215804 |
| 72 | MP0002722_abnormal_immune_system | 1.23944109 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 1.22431575 |
| 74 | MP0003878_abnormal_ear_physiology | 1.22431575 |
| 75 | MP0000858_altered_metastatic_potential | 1.21823377 |
| 76 | MP0003329_amyloid_beta_deposits | 1.20386987 |
| 77 | MP0003786_premature_aging | 1.19933159 |
| 78 | MP0003566_abnormal_cell_adhesion | 1.19057484 |
| 79 | MP0005023_abnormal_wound_healing | 1.17830981 |
| 80 | MP0003436_decreased_susceptibility_to | 1.15895393 |
| 81 | * MP0000313_abnormal_cell_death | 1.15866992 |
| 82 | MP0003763_abnormal_thymus_physiology | 1.14235312 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.14177178 |
| 84 | MP0005671_abnormal_response_to | 1.13497032 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 1.13265653 |
| 86 | MP0004233_abnormal_muscle_weight | 1.12516357 |
| 87 | MP0009785_altered_susceptibility_to | 1.10866744 |
| 88 | MP0008932_abnormal_embryonic_tissue | 1.10829265 |
| 89 | MP0001849_ear_inflammation | 1.10046781 |
| 90 | MP0004381_abnormal_hair_follicle | 1.09471679 |
| 91 | MP0002998_abnormal_bone_remodeling | 1.09290898 |
| 92 | MP0003879_abnormal_hair_cell | 1.09073947 |
| 93 | MP0003942_abnormal_urinary_system | 1.07989598 |
| 94 | MP0000015_abnormal_ear_pigmentation | 1.07366057 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 1.06541950 |
| 96 | MP0003283_abnormal_digestive_organ | 1.04672833 |
| 97 | MP0009379_abnormal_foot_pigmentation | 1.02869986 |
| 98 | MP0010155_abnormal_intestine_physiology | 1.02682308 |
| 99 | MP0001542_abnormal_bone_strength | 1.01617427 |
| 100 | MP0001915_intracranial_hemorrhage | 1.01324069 |
| 101 | MP0003091_abnormal_cell_migration | 1.00922788 |
| 102 | * MP0002429_abnormal_blood_cell | 0.99107450 |
| 103 | MP0003221_abnormal_cardiomyocyte_apopto | 0.98291259 |
| 104 | MP0009764_decreased_sensitivity_to | 0.97689001 |
| 105 | MP0006292_abnormal_olfactory_placode | 0.96338827 |
| 106 | MP0001800_abnormal_humoral_immune | 0.95597126 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 0.94186650 |
| 108 | MP0003448_altered_tumor_morphology | 0.92710850 |
| 109 | MP0001835_abnormal_antigen_presentation | 0.91815796 |
| 110 | MP0003567_abnormal_fetal_cardiomyocyte | 0.91650328 |
| 111 | MP0000750_abnormal_muscle_regeneration | 0.91567040 |
| 112 | MP0009053_abnormal_anal_canal | 0.90687200 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.90619247 |
| 114 | * MP0000716_abnormal_immune_system | 0.90454584 |
| 115 | MP0001663_abnormal_digestive_system | 0.89710840 |
| 116 | MP0000477_abnormal_intestine_morphology | 0.89177619 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.88716322 |
| 118 | MP0005501_abnormal_skin_physiology | 0.87800271 |
| 119 | MP0000371_diluted_coat_color | 0.87766026 |
| 120 | MP0002148_abnormal_hypersensitivity_rea | 0.87226633 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.87037348 |
| 122 | MP0003303_peritoneal_inflammation | 0.86307170 |
| 123 | MP0002132_abnormal_respiratory_system | 0.86222952 |
| 124 | MP0002092_abnormal_eye_morphology | 0.85737400 |
| 125 | MP0005390_skeleton_phenotype | 0.85706910 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.85523035 |
| 127 | MP0008770_decreased_survivor_rate | 0.84991200 |
| 128 | MP0000598_abnormal_liver_morphology | 0.84317939 |
| 129 | MP0004185_abnormal_adipocyte_glucose | 0.83335104 |
| 130 | MP0000609_abnormal_liver_physiology | 0.82889595 |
| 131 | MP0002111_abnormal_tail_morphology | 0.82657880 |
| 132 | MP0002254_reproductive_system_inflammat | 0.81464588 |
| 133 | MP0001845_abnormal_inflammatory_respons | 0.80568769 |
| 134 | MP0001873_stomach_inflammation | 0.80400899 |
| 135 | MP0009931_abnormal_skin_appearance | 0.80217846 |
| 136 | MP0008995_early_reproductive_senescence | 0.79984873 |
| 137 | MP0005174_abnormal_tail_pigmentation | 0.79644072 |
| 138 | MP0000604_amyloidosis | 0.79060081 |
| 139 | MP0002006_tumorigenesis | 0.78818682 |
| 140 | MP0002970_abnormal_white_adipose | 0.77619131 |
| 141 | MP0002452_abnormal_antigen_presenting | 0.77439407 |
| 142 | MP0002249_abnormal_larynx_morphology | 0.77013795 |
| 143 | MP0005310_abnormal_salivary_gland | 0.75648001 |
| 144 | MP0003828_pulmonary_edema | 0.74574137 |
| 145 | MP0001790_abnormal_immune_system | 0.73818727 |
| 146 | MP0005387_immune_system_phenotype | 0.73818727 |
| 147 | MP0002697_abnormal_eye_size | 0.73058989 |
| 148 | MP0003279_aneurysm | 0.73056576 |
| 149 | MP0002925_abnormal_cardiovascular_devel | 0.72784809 |
| 150 | MP0008469_abnormal_protein_level | 0.69753680 |
| 151 | MP0000428_abnormal_craniofacial_morphol | 0.67389145 |
| 152 | MP0005666_abnormal_adipose_tissue | 0.66187121 |
| 153 | MP0003866_abnormal_defecation | 0.64063538 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rib fusion (HP:0000902) | 4.80949494 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 4.58118864 |
| 3 | Pustule (HP:0200039) | 4.16642058 |
| 4 | Hypochromic anemia (HP:0001931) | 3.50039783 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.36823893 |
| 6 | Ependymoma (HP:0002888) | 3.34264819 |
| 7 | Rectovaginal fistula (HP:0000143) | 3.31905734 |
| 8 | Rectal fistula (HP:0100590) | 3.31905734 |
| 9 | Increased IgM level (HP:0003496) | 3.18944569 |
| 10 | Ulnar bowing (HP:0003031) | 3.17566611 |
| 11 | Intestinal fistula (HP:0100819) | 3.16703267 |
| 12 | Long palpebral fissure (HP:0000637) | 3.16057062 |
| 13 | Poikiloderma (HP:0001029) | 3.15725413 |
| 14 | Gastrointestinal infarctions (HP:0005244) | 3.13041428 |
| 15 | Vaginal fistula (HP:0004320) | 3.10110617 |
| 16 | Hypertensive crisis (HP:0100735) | 3.04588826 |
| 17 | Facial hemangioma (HP:0000329) | 3.02946661 |
| 18 | Basal cell carcinoma (HP:0002671) | 3.01665566 |
| 19 | Abnormality of the astrocytes (HP:0100707) | 2.99258441 |
| 20 | Astrocytoma (HP:0009592) | 2.99258441 |
| 21 | Tongue fasciculations (HP:0001308) | 2.95973265 |
| 22 | Short humerus (HP:0005792) | 2.95282393 |
| 23 | Recurrent bacterial skin infections (HP:0005406) | 2.89795468 |
| 24 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.88487797 |
| 25 | Abnormality of macrophages (HP:0004311) | 2.87574080 |
| 26 | Obstructive lung disease (HP:0006536) | 2.82560297 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82560297 |
| 28 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.81125457 |
| 29 | Hyperthyroidism (HP:0000836) | 2.77429251 |
| 30 | Annular pancreas (HP:0001734) | 2.76270036 |
| 31 | Recurrent abscess formation (HP:0002722) | 2.73570992 |
| 32 | Muscle fibrillation (HP:0010546) | 2.73225469 |
| 33 | Selective tooth agenesis (HP:0001592) | 2.71987454 |
| 34 | Vertebral hypoplasia (HP:0008417) | 2.71816554 |
| 35 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.71816554 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.70884628 |
| 37 | Disproportionate tall stature (HP:0001519) | 2.63228618 |
| 38 | Abnormality of the lower motor neuron (HP:0002366) | 2.62290623 |
| 39 | Polycythemia (HP:0001901) | 2.61991700 |
| 40 | Deep palmar crease (HP:0006191) | 2.60877759 |
| 41 | Abnormality of the thoracic spine (HP:0100711) | 2.60203307 |
| 42 | Turricephaly (HP:0000262) | 2.60168339 |
| 43 | Microcytic anemia (HP:0001935) | 2.59658150 |
| 44 | Cellulitis (HP:0100658) | 2.53102833 |
| 45 | Hyperacusis (HP:0010780) | 2.49731318 |
| 46 | Abnormality of the fingertips (HP:0001211) | 2.49073155 |
| 47 | Orthostatic hypotension (HP:0001278) | 2.46361823 |
| 48 | Abnormal hemoglobin (HP:0011902) | 2.44152764 |
| 49 | Thin bony cortex (HP:0002753) | 2.43576050 |
| 50 | Vertebral fusion (HP:0002948) | 2.43526348 |
| 51 | Reticulocytosis (HP:0001923) | 2.43414326 |
| 52 | Concave nail (HP:0001598) | 2.40633557 |
| 53 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.38444876 |
| 54 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.34532838 |
| 55 | Squamous cell carcinoma (HP:0002860) | 2.33988192 |
| 56 | Insomnia (HP:0100785) | 2.32369721 |
| 57 | Thoracic kyphosis (HP:0002942) | 2.31187204 |
| 58 | Metaphyseal cupping (HP:0003021) | 2.25225788 |
| 59 | Alopecia of scalp (HP:0002293) | 2.22549303 |
| 60 | Multiple enchondromatosis (HP:0005701) | 2.22248143 |
| 61 | Short 5th finger (HP:0009237) | 2.21640201 |
| 62 | Obstructive sleep apnea (HP:0002870) | 2.21244751 |
| 63 | Truncus arteriosus (HP:0001660) | 2.21029342 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.20932140 |
| 65 | Rectal prolapse (HP:0002035) | 2.19750774 |
| 66 | Pallor (HP:0000980) | 2.15741913 |
| 67 | Emphysema (HP:0002097) | 2.14362306 |
| 68 | Glioma (HP:0009733) | 2.12665278 |
| 69 | Neoplasm of the oral cavity (HP:0100649) | 2.12050221 |
| 70 | Myositis (HP:0100614) | 2.10261468 |
| 71 | Absent radius (HP:0003974) | 2.10026927 |
| 72 | Absent thumb (HP:0009777) | 2.09666030 |
| 73 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.08729933 |
| 74 | Rhabdomyosarcoma (HP:0002859) | 2.07300817 |
| 75 | Neoplasm of striated muscle (HP:0009728) | 2.05499766 |
| 76 | Heterotopia (HP:0002282) | 2.04786779 |
| 77 | Patellar aplasia (HP:0006443) | 2.04781692 |
| 78 | Achilles tendon contracture (HP:0001771) | 2.04463726 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.03034072 |
| 80 | Increased IgE level (HP:0003212) | 2.02886626 |
| 81 | Orchitis (HP:0100796) | 2.02541628 |
| 82 | Broad distal phalanx of finger (HP:0009836) | 2.02507256 |
| 83 | Spinal muscular atrophy (HP:0007269) | 2.01899313 |
| 84 | Missing ribs (HP:0000921) | 2.01719385 |
| 85 | Atelectasis (HP:0100750) | 2.01341023 |
| 86 | Bowed forearm bones (HP:0003956) | 1.99586037 |
| 87 | Bowing of the arm (HP:0006488) | 1.99586037 |
| 88 | Abnormality of reticulocytes (HP:0004312) | 1.99262149 |
| 89 | Broad alveolar ridges (HP:0000187) | 1.99123298 |
| 90 | Poikilocytosis (HP:0004447) | 1.97893929 |
| 91 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97889117 |
| 92 | Abnormality of the aortic arch (HP:0012303) | 1.97705766 |
| 93 | Abnormal platelet volume (HP:0011876) | 1.96969207 |
| 94 | Polygenic inheritance (HP:0010982) | 1.95985291 |
| 95 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.95440875 |
| 96 | Hemorrhage of the eye (HP:0011885) | 1.94081004 |
| 97 | Absent forearm bone (HP:0003953) | 1.92691627 |
| 98 | Aplasia involving forearm bones (HP:0009822) | 1.92691627 |
| 99 | Increased mean platelet volume (HP:0011877) | 1.91267136 |
| 100 | Colitis (HP:0002583) | 1.90234671 |
| 101 | Albinism (HP:0001022) | 1.89042829 |
| 102 | Gingivitis (HP:0000230) | 1.88987687 |
| 103 | Myocardial infarction (HP:0001658) | 1.87887138 |
| 104 | Congenital hip dislocation (HP:0001374) | 1.87792894 |
| 105 | Hypercortisolism (HP:0001578) | 1.87229317 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.86436255 |
| 107 | Mucopolysacchariduria (HP:0008155) | 1.86436255 |
| 108 | Pseudobulbar signs (HP:0002200) | 1.86084409 |
| 109 | Mitral regurgitation (HP:0001653) | 1.85274979 |
| 110 | Hyperparathyroidism (HP:0000843) | 1.85223899 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.85107268 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.85107268 |
| 113 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.84243610 |
| 114 | Abnormal vertebral ossification (HP:0100569) | 1.83560512 |
| 115 | Supranuclear gaze palsy (HP:0000605) | 1.82606172 |
| 116 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.82407557 |
| 117 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.82222679 |
| 118 | Easy fatigability (HP:0003388) | 1.81875909 |
| 119 | Peritonitis (HP:0002586) | 1.81785980 |
| 120 | Diaphragmatic weakness (HP:0009113) | 1.81540511 |
| 121 | Vertebral compression fractures (HP:0002953) | 1.81494612 |
| 122 | Cheilitis (HP:0100825) | 1.81371825 |
| 123 | Genu recurvatum (HP:0002816) | 1.81211877 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.80950728 |
| 125 | Syringomyelia (HP:0003396) | 1.80899689 |
| 126 | Spinal cord lesions (HP:0100561) | 1.80899689 |
| 127 | Increased serum ferritin (HP:0003281) | 1.80435942 |
| 128 | Supernumerary nipples (HP:0002558) | 1.80398170 |
| 129 | Purpura (HP:0000979) | 1.80263391 |
| 130 | Nasal polyposis (HP:0100582) | 1.80261181 |
| 131 | Cutaneous melanoma (HP:0012056) | 1.78381760 |
| 132 | Hypoparathyroidism (HP:0000829) | 1.77954403 |
| 133 | Abnormal number of erythroid precursors (HP:0012131) | 1.77352018 |
| 134 | Abnormality of the Achilles tendon (HP:0005109) | 1.77043798 |
| 135 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.75429633 |
| 136 | Hand muscle atrophy (HP:0009130) | 1.75143736 |
| 137 | Vertebral clefting (HP:0008428) | 1.74025193 |
| 138 | Cholelithiasis (HP:0001081) | 1.73897317 |
| 139 | Intestinal atresia (HP:0011100) | 1.73781142 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.72879149 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.72699821 |
| 142 | Acute lymphatic leukemia (HP:0006721) | 1.72151473 |
| 143 | Trismus (HP:0000211) | 1.72119785 |
| 144 | Urticaria (HP:0001025) | 1.71960637 |
| 145 | Lower limb hyperreflexia (HP:0002395) | 1.71145993 |
| 146 | Persistence of primary teeth (HP:0006335) | 1.70618226 |
| 147 | Spastic diplegia (HP:0001264) | 1.70452666 |
| 148 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.69976008 |
| 149 | Dysautonomia (HP:0002459) | 1.69937562 |
| 150 | Abnormality of T cell physiology (HP:0011840) | 1.68860169 |
| 151 | Medulloblastoma (HP:0002885) | 1.68854412 |
| 152 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.68277069 |
| 153 | Broad palm (HP:0001169) | 1.67688476 |
| 154 | Spontaneous hematomas (HP:0007420) | 1.67062823 |
| 155 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.66925571 |
| 156 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.66925571 |
| 157 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.66925571 |
| 158 | Abnormality of the motor neurons (HP:0002450) | 1.66878929 |
| 159 | Abnormal neuron morphology (HP:0012757) | 1.66878929 |
| 160 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.66589781 |
| 161 | Hypercalcemia (HP:0003072) | 1.66547851 |
| 162 | Abnormality of the nasal mucosa (HP:0000433) | 1.65702542 |
| 163 | Bowel incontinence (HP:0002607) | 1.65521676 |
| 164 | Patellar dislocation (HP:0002999) | 1.65290872 |
| 165 | Abnormality of the anterior horn cell (HP:0006802) | 1.65274231 |
| 166 | Degeneration of anterior horn cells (HP:0002398) | 1.65274231 |
| 167 | Agnosia (HP:0010524) | 1.64802872 |
| 168 | Myopathic facies (HP:0002058) | 1.64676876 |
| 169 | Abnormal number of incisors (HP:0011064) | 1.64372801 |
| 170 | Entropion (HP:0000621) | 1.64338829 |
| 171 | Gastrointestinal inflammation (HP:0004386) | 1.63954090 |
| 172 | Hemivertebrae (HP:0002937) | 1.61731981 |
| 173 | Abnormal large intestine physiology (HP:0012700) | 1.61377197 |
| 174 | Decreased motor nerve conduction velocity (HP:0003431) | 1.61353973 |
| 175 | Renal cell carcinoma (HP:0005584) | 1.60404197 |
| 176 | Joint stiffness (HP:0001387) | 1.60289707 |
| 177 | Partial duplication of thumb phalanx (HP:0009944) | 1.60269484 |
| 178 | Retrobulbar optic neuritis (HP:0100654) | 1.60245751 |
| 179 | Skin tags (HP:0010609) | 1.59306898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 3.90976049 |
| 2 | PRPF4B | 3.53934796 |
| 3 | CDK12 | 3.42019803 |
| 4 | SMG1 | 3.28308640 |
| 5 | MAP3K10 | 3.15673760 |
| 6 | MAPK15 | 2.50973023 |
| 7 | DDR2 | 2.41900627 |
| 8 | EEF2K | 2.40621225 |
| 9 | MAP3K11 | 2.38815903 |
| 10 | PIM2 | 2.37648134 |
| 11 | IRAK3 | 2.30661919 |
| 12 | ERN1 | 2.09721281 |
| 13 | MATK | 2.05260939 |
| 14 | MAP3K6 | 2.02374050 |
| 15 | PIM1 | 2.01476868 |
| 16 | BMX | 2.00356972 |
| 17 | TYRO3 | 1.96577590 |
| 18 | TRIB3 | 1.92871138 |
| 19 | IRAK4 | 1.79196990 |
| 20 | EPHA2 | 1.77738034 |
| 21 | DYRK1B | 1.76879681 |
| 22 | MARK2 | 1.73030147 |
| 23 | STK10 | 1.71349266 |
| 24 | GRK6 | 1.71027332 |
| 25 | CDK7 | 1.70262402 |
| 26 | MAP4K1 | 1.67608862 |
| 27 | RIPK4 | 1.67532943 |
| 28 | CDK6 | 1.61388792 |
| 29 | CSK | 1.51043611 |
| 30 | NEK2 | 1.48014424 |
| 31 | FLT3 | 1.46333298 |
| 32 | DYRK3 | 1.45874670 |
| 33 | PDGFRA | 1.45059260 |
| 34 | PKN2 | 1.43399353 |
| 35 | RPS6KB2 | 1.40509719 |
| 36 | MAP3K3 | 1.38445848 |
| 37 | PRKD2 | 1.37136838 |
| 38 | CAMK1D | 1.35426143 |
| 39 | MAP3K13 | 1.31819702 |
| 40 | FGR | 1.29586659 |
| 41 | MAP3K1 | 1.29405908 |
| 42 | RPS6KA2 | 1.24016625 |
| 43 | ARAF | 1.22939461 |
| 44 | BRAF | 1.22208067 |
| 45 | EPHB1 | 1.21483910 |
| 46 | DAPK1 | 1.14616153 |
| 47 | MTOR | 1.12592576 |
| 48 | IRAK2 | 1.10733008 |
| 49 | KSR2 | 1.09943105 |
| 50 | CDK4 | 1.08532509 |
| 51 | ALK | 1.06946897 |
| 52 | BLK | 1.06824359 |
| 53 | CHEK2 | 1.05298538 |
| 54 | FES | 1.02868660 |
| 55 | MAPK11 | 1.00866533 |
| 56 | SIK3 | 0.99925567 |
| 57 | MAPKAPK3 | 0.97339481 |
| 58 | NME2 | 0.96813504 |
| 59 | CDC7 | 0.96638377 |
| 60 | RPS6KC1 | 0.95892093 |
| 61 | RPS6KL1 | 0.95892093 |
| 62 | PAK4 | 0.95544666 |
| 63 | SCYL2 | 0.93913690 |
| 64 | PLK1 | 0.93011783 |
| 65 | UHMK1 | 0.92957119 |
| 66 | LATS2 | 0.91684079 |
| 67 | TGFBR2 | 0.90149751 |
| 68 | RPS6KA6 | 0.89376395 |
| 69 | JAK3 | 0.87268247 |
| 70 | MAP3K14 | 0.83937157 |
| 71 | ACVR1B | 0.83517211 |
| 72 | MAP3K9 | 0.83312761 |
| 73 | TYK2 | 0.82579890 |
| 74 | CDK19 | 0.81676548 |
| 75 | YES1 | 0.81047011 |
| 76 | ZAP70 | 0.79000350 |
| 77 | TBK1 | 0.78896678 |
| 78 | RPS6KA1 | 0.78667154 |
| 79 | PDPK1 | 0.78472849 |
| 80 | CSF1R | 0.77047594 |
| 81 | MAP3K8 | 0.76918034 |
| 82 | TESK2 | 0.76374157 |
| 83 | FGFR4 | 0.75713972 |
| 84 | ATR | 0.75129500 |
| 85 | SIK1 | 0.74643506 |
| 86 | PTK2 | 0.72808012 |
| 87 | GSK3A | 0.72586284 |
| 88 | MAP2K2 | 0.72514755 |
| 89 | BTK | 0.71937660 |
| 90 | MAP2K3 | 0.69571237 |
| 91 | HIPK2 | 0.69401431 |
| 92 | TNK2 | 0.68700497 |
| 93 | RIPK1 | 0.68100162 |
| 94 | WEE1 | 0.67706348 |
| 95 | SIK2 | 0.67489324 |
| 96 | STK4 | 0.66808039 |
| 97 | TAOK1 | 0.64622258 |
| 98 | BUB1 | 0.64332150 |
| 99 | TTK | 0.63932004 |
| 100 | IKBKE | 0.63334924 |
| 101 | CHEK1 | 0.63184726 |
| 102 | HCK | 0.63013964 |
| 103 | CDK2 | 0.62679015 |
| 104 | MARK3 | 0.61480640 |
| 105 | AURKA | 0.60230932 |
| 106 | CAMK1G | 0.59963018 |
| 107 | TAOK2 | 0.56803863 |
| 108 | MAPK12 | 0.56223755 |
| 109 | SGK3 | 0.55954131 |
| 110 | MAP3K7 | 0.55465569 |
| 111 | CDC42BPA | 0.54795138 |
| 112 | MAPKAPK2 | 0.54624810 |
| 113 | BRD4 | 0.54586238 |
| 114 | * IKBKB | 0.53611094 |
| 115 | NEK1 | 0.51882430 |
| 116 | STK11 | 0.51706723 |
| 117 | AURKB | 0.51170517 |
| 118 | JAK2 | 0.50868176 |
| 119 | AKT2 | 0.50633929 |
| 120 | PRKD3 | 0.50571681 |
| 121 | LRRK2 | 0.49064080 |
| 122 | IRAK1 | 0.47484947 |
| 123 | TRPM7 | 0.47459505 |
| 124 | PTK6 | 0.47321359 |
| 125 | TTN | 0.47212016 |
| 126 | PAK2 | 0.46616447 |
| 127 | RPS6KA4 | 0.46246317 |
| 128 | DAPK3 | 0.45547533 |
| 129 | WNK1 | 0.45181426 |
| 130 | PDK1 | 0.44651922 |
| 131 | MAPK1 | 0.44521627 |
| 132 | DYRK2 | 0.44195128 |
| 133 | EGFR | 0.44050969 |
| 134 | * CHUK | 0.42916565 |
| 135 | PIK3CA | 0.41158630 |
| 136 | LCK | 0.41006192 |
| 137 | PINK1 | 0.38614927 |
| 138 | MAP2K4 | 0.38102409 |
| 139 | ABL2 | 0.37747157 |
| 140 | ATM | 0.37088939 |
| 141 | TGFBR1 | 0.37031705 |
| 142 | TLK1 | 0.36059132 |
| 143 | PRKCI | 0.35583588 |
| 144 | EPHB2 | 0.34923424 |
| 145 | MAPK3 | 0.33851234 |
| 146 | PRKAA1 | 0.32785433 |
| 147 | MOS | 0.32723022 |
| 148 | LYN | 0.31627932 |
| 149 | AKT1 | 0.30335469 |
| 150 | PRKCZ | 0.27879037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 3.25309076 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.15213799 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 2.92741061 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31285808 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.26840469 |
| 6 | Spliceosome_Homo sapiens_hsa03040 | 2.04119453 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.03579304 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.01515636 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.00651265 |
| 10 | * p53 signaling pathway_Homo sapiens_hsa04115 | 1.97593538 |
| 11 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.87902481 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.83884598 |
| 13 | Sulfur relay system_Homo sapiens_hsa04122 | 1.78954973 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.70641801 |
| 15 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.69067893 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 1.68719035 |
| 17 | Bladder cancer_Homo sapiens_hsa05219 | 1.66265432 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.64004899 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.61363446 |
| 20 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.56901073 |
| 21 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.56729365 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.54577564 |
| 23 | Ribosome_Homo sapiens_hsa03010 | 1.51808520 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.41855679 |
| 25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.38155635 |
| 26 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.31950116 |
| 27 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.31125403 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27511707 |
| 29 | Hepatitis C_Homo sapiens_hsa05160 | 1.27259787 |
| 30 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.26705999 |
| 31 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23730725 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21372254 |
| 33 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20935340 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.19341905 |
| 35 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.19340177 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.18381794 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17498361 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.16551474 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 1.15389988 |
| 40 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14308339 |
| 41 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.13440798 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11460756 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.10568587 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 1.09663606 |
| 45 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.07510759 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 1.07500302 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05941743 |
| 48 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.05733060 |
| 49 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.05395454 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05131032 |
| 51 | * Hippo signaling pathway_Homo sapiens_hsa04390 | 1.05086945 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03399133 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 1.02452105 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.02089443 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.01412531 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.01351600 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 1.01015316 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.00522101 |
| 59 | * Apoptosis_Homo sapiens_hsa04210 | 1.00115532 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99978931 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98893730 |
| 62 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97925929 |
| 63 | * Measles_Homo sapiens_hsa05162 | 0.97110307 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.96657043 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.95341482 |
| 66 | Hepatitis B_Homo sapiens_hsa05161 | 0.94423309 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.92643018 |
| 68 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90707982 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89322881 |
| 70 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88854438 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88483110 |
| 72 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.87555499 |
| 73 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.87378795 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.87251551 |
| 75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.87120467 |
| 76 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86574928 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86136077 |
| 78 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.84951571 |
| 79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84795729 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.84466585 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84428487 |
| 82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.84211810 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84204690 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84034739 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83851256 |
| 86 | Salmonella infection_Homo sapiens_hsa05132 | 0.83401563 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.83037133 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.80748914 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80643818 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.80462910 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79894814 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77551776 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76201575 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73568889 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72663873 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.72473093 |
| 97 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72220550 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70623780 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70020871 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69087967 |
| 101 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68972858 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.67451943 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67110759 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.64133521 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64076559 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63915492 |
| 107 | Melanoma_Homo sapiens_hsa05218 | 0.63538534 |
| 108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.63130427 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.62424369 |
| 110 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61935440 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.61908733 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61758618 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61224864 |
| 114 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61222555 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.61093871 |
| 116 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60907137 |
| 117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.60756752 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.60653221 |
| 119 | Phagosome_Homo sapiens_hsa04145 | 0.60340978 |
| 120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59332265 |
| 121 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57435005 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57028030 |
| 123 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56515350 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56262397 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55706521 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.55041960 |
| 127 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.54308920 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53366398 |
| 129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53323232 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52679909 |
| 131 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52654808 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52444774 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.50585655 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50415748 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47766891 |
| 136 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44745165 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.43447304 |
| 138 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.43309039 |
| 139 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42601393 |
| 140 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42469277 |
| 141 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.42396950 |
| 142 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.40672191 |
| 143 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.40061590 |
| 144 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.37973992 |

